ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,535, issued on Feb. 17, was assigned to Mederis Diabetes LLC (Sugar Land, Texas).
"Peptide pharmaceuticals for insulin resistance" was invented by John J. Nestor (Sugar Land, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are methods of syntheses and therapeutic uses of covalently modified peptides and/or proteins. The covalently modified peptides and/or proteins allow for improved pharmaceutical properties of peptide and protein-based therapeutics."
The patent was filed on Feb. 26, 2024, under Application No. 18/587,927.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/neta...